SCRA Technology Ventures Company Signs Research Agreement

by Business Wire • 2015/05/06 • 0 Comments

SUMMERVILLE, S.C.--(BUSINESS WIRE)--SCRA Technology Ventures company, FirstString Research, announces CRADA to advance therapeutic for diabetic keratopathy and persistent corneal defects.

← Mati Therapeutics Expands Patent Portfolio

Trained nurses administer AMD treatments as safely and effectively as doctors →

Post navigation